Curasight A/S (NGM:CURAS)
Sweden · Delayed Price · Currency is SEK · Price in DKK 14.10
+0.35 (2.55%)
At close: May 5, 2026
Curasight Earnings Call Transcripts
Fiscal Year 2025
-
A rights issue seeks up to DKK 100 million to fund pivotal studies in brain and prostate cancer, with about half already secured from investors and management. The capital will extend runway to H2 2026, support key clinical milestones, and enhance partnership opportunities.